Mike Thomas provides fractional CEO services for several medical technology, digital health, and medical device startups. He also is a Senior Commercialization Advisor for the NobleReach Foundation. He has managed a portfolio of over a dozen DARPA-funded performers and, at the request of the Office of Science and Technology Policy (OSTP), was a founding architect of the Advanced Research Projects Agency for Health (ARPA-H).

Mike is a Managing Partner for Bold Brain Capital, a VC firm that invests in AI enabled startups in the imaging markets. He was a VC at the Inova Health System Strategic Investments (ISI) in northern VA. Prior to that, he was a serial healthcare technology CEO for over 20 years. Mike raised $125 million in capital and drove shareholder returns that ranged from 4x to 80x, including one IPO and one acquisition. Previously, Mike was CEO of iSonea Ltd (ASX:ISN), a publicly traded global mobile health app developer and medical device manufacturer in the respiratory disease market, where he increased the company’s market capitalization from $4 million to $250 million in less than 3 years. He is a former board member of AdvaMed, the global medical device association.

Mike was most recently the founder and CEO of Appian Medical, a digital health firm that served the sleep apnea market, and Wakyn Sleep Technologies, Inc., an AI med device firm that developed a rapid (5 min.), awake diagnostic test for OSA. He is currently a member of the Board of Directors for Tanzen Medical, Inc., Echelon MedTech, and Board Chairman for ODY-C, Inc.